From mRNA to Nasal Delivery, Vaccine Innovation Is Creating New Growth
The vaccine market is becoming an increasingly strategic component of preventive healthcare as governments, healthcare organizations, and pharmaceutical companies continue to prioritize immunization, outbreak preparedness, and long-term disease prevention. The market was valued at USD 72.8 billion in 2025 and is estimated to reach USD 78.1 billion in 2026, before expanding to USD 115.8 billion...
0 Comments 0 Shares 54 Views 0 Reviews